Dr Reddys Laboratories (RDY) Change in Taxes (2009 - 2026)
Dr Reddys Laboratories (RDY) posted Change in Taxes of -$20.5 million for Q2 2026, up 68.37% on a QoQ basis from -$64.9 million in Q3 2025, and up 44.93% year-over-year from -$14.2 million in Q2 2025.
Analysis
Dr Reddys Laboratories (RDY) Change in Taxes (2009 - 2026) Analysis & Trends
Dr Reddys Laboratories has reported Change in Taxes for 17 years, with the latest figure at -$20.5 million in Q2 2026.
- On a quarterly basis, Change in Taxes rose 44.93% year-over-year to -$20.5 million in Q2 2026; TTM through Jun 2026 was -$208.9 million, a 0.18% change from a year earlier, with the FY2026 full-year figure at -$144.0 million, up 38.46% from the prior year.
- Change in Taxes was -$20.5 million for Q2 2026 at Dr Reddys Laboratories, up from -$64.9 million in the prior quarter.
- The five-year high for Change in Taxes was -$14.8 million in Q2 2022, with the low at -$86.2 million in Q3 2024.
- Average Change in Taxes over 5 years is -$44.8 million, with a median of -$40.6 million recorded in 2022.
- The sharpest annual moves came in 2023 and 2026: Change in Taxes slumped 150.12% in 2023, then surged 44.93% in 2026.
- Over 5 years, Change in Taxes stood at -$28.9 million in 2022, then plunged by 150.12% to -$72.4 million in 2023, then retreated by 19.14% to -$86.2 million in 2024, then gained by 24.79% to -$64.9 million in 2025, then soared by 68.37% to -$20.5 million in 2026.
- The last three Change in Taxes figures came in at -$20.5 million (Q2 2026), -$64.9 million (Q3 2025), and -$37.3 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.63 Bn | 38.97 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.19 Bn | 18.30 Bn | 1.46 Bn | 40.90 Mn |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn | -20.51 Mn |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.36 Bn | 520.30 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -208,000.00 |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | -1.77 Mn |
| 8 | Amphastar Pharmaceuticals | 995.52 Mn | 705.40 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 404.35 Mn | 363.10 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -20.51 Mn |
| Sep 30, 2025 | -64.86 Mn |
| Jun 30, 2025 | -37.25 Mn |
| Sep 30, 2024 | -86.24 Mn |
| Jun 30, 2024 | -18.35 Mn |
| Mar 31, 2024 | -66.64 Mn |
| Dec 31, 2023 | -72.38 Mn |
| Sep 30, 2023 | -73.82 Mn |
| Jun 30, 2023 | -29.02 Mn |
| Mar 31, 2023 | -44.99 Mn |
| Dec 31, 2022 | -28.94 Mn |
| Sep 30, 2022 | -43.91 Mn |
| Jun 30, 2022 | -14.77 Mn |
| Mar 31, 2022 | -25.31 Mn |
| Dec 31, 2021 | -26.63 Mn |
| Sep 30, 2021 | -31.76 Mn |
| Jun 30, 2021 | -16.08 Mn |
| Mar 31, 2021 | -31.28 Mn |
| Dec 31, 2020 | -18.39 Mn |
| Sep 30, 2020 | -16.02 Mn |